A new high-dose chemotherapy regimen has been shown to improve survival of children with high-risk neuroblastoma, a common pediatric cancer, according to a European clinical trial published Sunday.
Jun 06, 2011
not rated yet
1
Scientists from the Florida campus of The Scripps Research Institute have uncovered a potentially important new therapeutic target that could prevent stress-related cell death, a characteristic of neurodegenerative diseases ...
Jun 02, 2011
5 / 5 (2)
0
(PhysOrg.com) -- A new study conducted by researchers at the University of Birmingham has identified a 21 day treatment threshold to facilitate renal recovery and significantly improve survival rates of myeloma or Kahler's ...
Apr 22, 2011
not rated yet
0
Patients with Parkinson's disease (PD) suffer a specific loss of dopaminergic neurons from the midbrain region that controls motor function. The exact mechanism of this selective neurodegeneration is unclear, ...
Mar 07, 2011
5 / 5 (1)
0
Work led by St. Jude Children's Research Hospital scientists identified how cells flip a switch between cell survival and cell death that involves a protein called FLIP.
Mar 02, 2011
5 / 5 (1)
0
|
Investigators at the National Institutes of Health have observed that the survival rate of people with a rare immunodeficiency disease called chronic granulomatous disease (CGD) is greatly improved when even very low levels ...
Dec 30, 2010
not rated yet
0
Researchers at Virginia Commonwealth University have discovered that a gene well known for its involvement in tumor cell development, growth and metastasis also protects cancer cells from being destroyed by chemotherapy. ...
Nov 22, 2010
5 / 5 (1)
0
|
A discovery by Walter and Eliza Hall Institute researchers in Melbourne, Australia, reported in today's edition of Science, is set to rewrite a long-held belief about how the body's immune system establishes its me ...
Oct 07, 2010
4.7 / 5 (10)
0
|
(PhysOrg.com) -- Most organisms need iron to survive, but too much iron is toxic, and can cause fatal organ failure. The same is true inside cells, where iron balance must also be maintained. In a study published today in ...
Aug 03, 2010
5 / 5 (1)
0
Allogeneic (donor-derived) stem cell transplant (alloSCT) may be a promising option for patients with treatment-resistant chronic lymphocytic leukemia (CLL), regardless of the patient's underlying genetic abnormalities, according ...
Jul 02, 2010
not rated yet
0
City of Hope researchers received approval from the U.S. Food and Drug Administration (FDA) to conduct the first-in-human study of a neural stem cell-based therapy targeting recurrent high-grade gliomas, the most aggressive ...
Jun 08, 2010
not rated yet
0
When kidney cancer spreads to other body parts, patients usually receive a poor prognosis. A new Mayo Clinic study examined the benefits of surgical treatment of kidney cancer, specifically renal cell carcinoma, and how patients ...
Jun 02, 2010
not rated yet
0
New research discovers a combination of drugs that may prove to be a more effective treatment for a lethal form of leukemia. The study, published by Cell Press in the May issue of the journal Cancer Cell, reports that the ne ...
May 17, 2010
not rated yet
0
The maximal standardized uptake value (called SUVmax) measured from FDG PET readings taken from the primary tumor in head and neck squamous cell carcinoma patients before treatment is a strong predictor of disease-specific ...
Feb 25, 2010
not rated yet
0
Cancer researchers of the Max Delbrück Center for Molecular Medicine (MDC) Berlin-Buch, Germany, have gained new insights into how cells react to DNA damage. Dr. Michael Stilmann, Dr. Michael Hinz and Professor Claus Scheidereit ...
Nov 16, 2009
not rated yet
0
